Opentrons Partners With Zymo Research To Offer an Affordable, Automated COVID-19 Testing Platform
Summary
BROOKLYN, N.Y.--(BUSINESS WIRE)--Zymo Research Corp, a California-based life science reagent company and Opentrons Labworks, Inc, makers of affordable and easy-to-use lab robotics, have partnered to create a robust engine for SARS-CoV-2 molecular testing. The automated RNA extraction pipeline created with the Opentrons OT-2 liquid handling robot, verified labware, and magnetic module together with Zymo Research’s Quick-DNA/RNA Viral MagBead Kit can serve as the foundation for any lab seeking to perform high-sensitivity SARS-CoV-2 testing. “We are proud to be able to bring this affordable, easy-to-use system to the market very quickly in partnership with Zymo Research.” Additionally, any OT-2 robot user can download open-source scripts to automate Quick-DNA/RNA Viral MagBead Kit to perform the protocol in their own lab. We are proud to partner with a company like Opentrons to produce a simple solution that facilitates much-needed testing,” said Marc Van Eden, PhD, Vice President of Business Development at Zymo Research. Historically recognized as the leader in epigenetics, Zymo Research is breaking boundaries with novel solutions for sample collection, microbiomic measurements, and NGS technologies that are high quality and simple to use.